Navigation Links
Exercise testing may help predict seriousness of mitral regurgitation
Date:12/11/2007

NEW YORK (Dec. 11, 2007) -- In as many as one in five people over age 55, when the heart contracts to send blood around the body, some degree of backward leakage occurs across the mitral valve, a condition known as mitral regurgitation (MR). When sufficiently severe, MR causes buildup of blood in the lungs, leading to difficulty in breathing (dyspnea, or "shortness of breath"), a serious condition called congestive heart failure. MR also can cause heart rhythm irregularities (arrhythmias) such as atrial fibrillation, which can lead to strokes and other problems, and ventricular tachycardia, which can cause sudden death.

A new study finds that monitoring the capacity of these patients to exercise on a treadmill -- an evaluation called exercise tolerance testing (ETT) -- may be useful in predicting the condition's progression and whether the patient will need surgery. Led by NewYork-Presbyterian Hospital/Weill Cornell Medical Center, the research is published in the American Journal of Cardiology.

"Mitral regurgitation can be very benign, going unnoticed for many years, or can be severe, impeding the heart's proper function and leading to complications, even death. There are few accurate ways to predict the seriousness of a single case, and these methods require fairly sophisticated and expensive imaging. Our study shows that exercise tolerance testing, a simple procedure often performed in doctors' offices, is an excellent tool for predicting if the patient is deteriorating and needs surgery," says Dr. Jeffrey S. Borer, a study co-author ; director of the Howard Gilman Institute for Valvular Heart Diseases at NewYork-Presbyterian/Weill Cornell; and the Gladys and Roland Harriman Professor of Cardiovascular Medicine and professor of cardiovascular medicine in cardiothoracic surgery at Weill Cornell Medical College.

"We found that exercise testing is a simple and relatively inexpensive way to predict outcomes. Patients with mitral regurgitation who perform well on the treadmill will likely remain healthy and not have to undergo further testing for a number of years. This gives these patients peace of mind," says principal investigator Dr. Phyllis G. Supino, associate research professor of public health in medicine and associate research professor of public health at Weill Cornell Medical College.

Developed in its most simple form in the 1920s, exercise tolerance testing (ETT) is used commonly to assess the progression of coronary artery disease and the severity of aortic stenosis.

In mitral regurgitation, the mitral valve does not close completely, as it should, when the heart contracts, allowing blood to flow backward instead of forward, limiting blood flow to the body. Symptoms include shortness of breath, fatigue, cough, heart palpitations, swollen feet or ankles, and excessive urination. A characteristic heart murmur can be heard with a stethoscope.

In the current study, researchers followed 38 patients with chronic severe nonischemic MR (that is, MR not due to a prior heart attack) for an average of seven years. All underwent ETT at study entry. Patients who could continue exercising for 15 minutes or longer (of a maximum total of 18 minutes) had a fivefold lower annual risk of developing heart failure or other evidence of severe heart dysfunction necessitating surgery, compared to patients who were unable to exercise for that length of time.

In patients with chronic severe nonischemic MR, progression to surgical indications generally is rapid. There are two surgical options for the treatment of MR: mitral valve replacement and mitral valve repair.


'/>"/>

Contact: Emily Berlanstein
eab2007@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. Exercise and yoga improves quality of life in women with early-stage breast cancer
2. Studies Prove Exercise Can Heal the Body Mind and Soul
3. 1 in 3 Varsity Athletes Has Exercise-Induced Asthma
4. Using the Internet to Promote Exercise
5. Less than 3 percent of UK 11-year-olds take enough exercise
6. Study fuels debate over whether exercise and body size influence ovarian cancer risk
7. Creatine in addition to exercise enhances strength in older adults
8. American Council on Exercise Offers 10 Tips for Surviving the Holidays
9. Highlands Acquisition Corp. Announces Exercise of Over-Allotment Option
10. Exercise And Health: Use Your Heart Rate As a Guide
11. Nine of 10 Women Attempt Exercise Goals After Initial Failure, Survey Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... measurement firms. The ranking is based on reported data for 2015 performance ... health systems, ambulatory surgical centers, clinically integrated networks, and many of the nation’s ...
(Date:12/6/2016)... ... December 06, 2016 , ... The NALA, a boutique marketing ... Bear Cancer Foundation (TBCF), a nonprofit 501(C)(3) organization providing financial and emotional support ... Obispo counties. To assist TBCF, the NALA recently hosted a Thanksgiving food drive that ...
(Date:12/6/2016)... ... December 06, 2016 , ... Healthcare leaders from ... regulations at the 7th annual Health IT Leadership Summit, to be held Wed., ... for the Centers for Medicare & Medicaid Services (CMS), will be the morning ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... is proud to announce it has added CXC Solutions (CXC) as a new ... These solutions are tailored to help benefits advisors reduce operating costs and ...
(Date:12/6/2016)... ... December 06, 2016 , ... Experimentation involving ... and development, largely due to its potential for revolutionizing human disease treatment. There ... human induced pluripotent stem cells (hiPSCs). , Both platforms have distinct advantages ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... NEW YORK , Dec. 5, 2016 Special ... collection of samples such as fluid and cells from organs ... advanced features, shapes, and sizes. The global market for special ... increasing geriatric population. In terms of revenue, the global special ... of 7.4% during the forecast period (2016–2026) and is expected ...
(Date:12/5/2016)... THE WOODLANDS, Texas , Dec. 5, 2016 /PRNewswire/ ... ) announced top-line results today from a Phase 2 ... inhibitor, conducted by Lexicon in collaboration with JDRF, the ... The purpose of this Phase 2 clinical trial, ... assess the effects of a once-daily 400 mg dose ...
(Date:12/5/2016)... 5, 2016 According to a new market ... Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, ... market is projected to reach USD 779.8 Million by 2021 from ... during the forecast period of 2016 to 2021. ... ...
Breaking Medicine Technology: